Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

October 09, 2015 8:54 PM ET


Company Overview of NovaCardia, Inc.

Company Overview

NovaCardia, Inc. develops drugs to treat cardiovascular diseases. The company develops KW-3902, an adenosine A1 receptor antagonist, which is in Phase III clinical trials for the treatment of the acute form of congestive heart failure in patients with renal impairment and fluid overload. It also develops an oral formulation of KW-3902 for the treatment of chronic congestive heart failure. In addition, the company develops K201 (JTV-519) for the treatment of atrial fibrillation, an irregular heartbeat. The company was founded in 2001 and is headquartered in San Diego, California. As of September 11, 2007, NovaCardia, Inc. operates as a subsidiary of Merck & Co. Inc.

12750 High Bluff Drive

Suite 300

San Diego, CA 92130

United States

Founded in 2001

11 Employees





Key Executives for NovaCardia, Inc.

NovaCardia, Inc. does not have any Key Executives recorded.

Similar Private Companies By Industry

Company Name Region
Trana Discovery, Inc. United States
ALIGN Pharmaceuticals, LLC United States
Meridian Animal Health, LLC United States
Cebix Incorporated United States
Symmetrix Pharmaceuticals, LLC United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NovaCardia, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at